Inovio Pharmaceuticals Inc. (Nasdaq: INO) announced that its synthetic flu vaccine protected multiple animal models from all major deadly strains of H1 influenza viruses from the last 100 year. Shares of the biopharmaceutical leaped $1.05 to close at $5.69.
Positive results for Inovio Pharmaceuticals' flu vaccine
January 23, 2018 at 16:30 PM EST
